1[1]Komaroff A L, Buchwald D S. Chronic fatigue syndrome: an update[J]. Annu Rev Med, 1998, 49: 1-13.
2[2]Fukuda K, Straus S E, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study[J]. Ann Intern Med, 1994, 121: 953-955.
3[3]Shephard R J. Chronic fatigue syndrome-an update. Sports Med, 2001, 158: 2038-2042.
4[4]Gow J W, Simpson K, Behan P O, et al. Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection[J]. Clin Infect Dis, 2001, 33: 2080-2091.
5[5]Soto N E, Straus S E. Chronic fatigue syndrome and herpesviruses: the Fading Evidence[J]. Herpes, 2000, 7: 46-50.
6[6]Craig T, Kakumanu S. Chronic fatigue syndrome: evaluation and treatment[J]. Am Fam Physician, 2002, 65: 1083-1090.
7[7]Patarca R. Cytokines and chronic fatigue syndrome[J]. Ann N Y Acad Sci, 2001, 933: 185-200.
8[8]Cleare A J, Miell J, Heap E, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy[J]. J Clin Endocrinol Metab, 2001, 86: 3545-3554.
9[9]Rowe P C, Calkins H, DeBusk K, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial[J]. JAMA, 2001, 285: 52-59.
10[10]Rowe P C, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome[J]. Am J Med, 1998, 105: 15S-21S.
